Itraconazole in the management of chronic dermatophytosis.

[1]  R. Hay,et al.  An evaluation of itraconazole in the management of onychomycosis , 1988, The British journal of dermatology.

[2]  N. Cox,et al.  Comparison of ketoconazole and griseofulvin in the treatment of tinea pedis. , 1987, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[3]  R. Hay Recent advances in the management of fungal infections. , 1987, The Quarterly journal of medicine.

[4]  R. Hay,et al.  A comparison of tioconazole 28% nail solution versus base as an adjunct to oral griseofulvin in patients with onychomycosis , 1987, Clinical and experimental dermatology.

[5]  H. Degreef,et al.  Itraconazole in the treatment of dermatophytoses: a comparison of two daily dosages. , 1987, Reviews of infectious diseases.

[6]  A. Bonifaz,et al.  Itraconazole in the treatment of superficial mycoses: an open trial of 40 cases. , 1987, Reviews of infectious diseases.

[7]  R. Hay,et al.  A comparative double blind study of ketoconazole and griseofulvin in dermatophytosis , 1985, The British journal of dermatology.

[8]  C. Vroey The epidemiology of ringworm (dermatophytosis) , 1985 .

[9]  J. V. van Cutsem,et al.  Itraconazole, a new triazole that is orally active in aspergillosis , 1984, Antimicrobial Agents and Chemotherapy.

[10]  M. Jacobs,et al.  Infection caused by vancomycin-resistant Streptococcus sanguis II , 1984, Antimicrobial Agents and Chemotherapy.

[11]  H. Jones,et al.  Griseofulvin-resistant dermatophytosis correlates with in vitro resistance. , 1981, Archives of dermatology.

[12]  E. Prevost Nonfluorescent tinea capitis in Charleston, SC. A diagnostic problem. , 1979, JAMA.

[13]  W. Lobitz,et al.  Immunological reactivity in dermatophytosis , 1974, The British journal of dermatology.

[14]  R. Davies,et al.  Mycological and Clinical Evaluation of Griseofulvin for Chronic Onychomycosis , 1967, British medical journal.